5 October–11 October 2026 · Monday–Sunday · ISO week numbering
Reports are filed by their AKN24 edition or added date. Original publication dates, sources and limitations remain with each report. Dates below show the complete week; a date does not imply a report was published that day.
AKN24 · 11 OCTOBER 2026 · 2 MIN READ WITH LINKED CARDS
Breathwork, Meditation & Preparation
This 11 October briefing distinguishes measured changes, participants’ accounts and a testable proposal. Publication dates and new coverage dates remain separate.
Breathwork · new coverage, August paper: Imaging found reduced blood flow but no significant group-level default-mode-network change. An exploratory association depended on analysis choices. Findings, primary source and limitations →
Meditation · 9 October · qualitative: Accounts from students describe awareness, care and difficulties. They do not establish lasting behavioural benefit. Study and evidence framing →
Psilocybin preparation · 8 October · theory: A bodily-awareness framework offers a hypothesis for testing, rather than completed efficacy results. Proposal and unresolved questions →
Issued: NOAA / SWPC, 11 October 2026 at 00:30 UTC (10 October, 17:30 PDT).
Observation: Maximum three-hour Kp in the preceding day was 7 — G3, Strong. Forecast: G1–G2 conditions were forecast on 11–12 October; their timing and intensity remain uncertain.
Interpretation: NOAA cites anticipated CME arrivals and possible coronal-hole stream influence. Hypothesis / testimony: No additional newsroom hypothesis; testimony not applicable. Speculation boundary: No human health, mood or consciousness effects are inferred.
Big Question evidence ratings remain unchanged. Observation, interpretation, hypothesis, testimony, speculation and unresolved questions are labelled in each linked card.
RESEARCH WATCH · 11 OCTOBER 2026 · PRELIMINARY SYNTHESIS
Altered States: Shared Patterns, Uneven Evidence
A newly surfaced review compares meditation, hypnosis and psychedelics. Only meditation produced effects surviving multiple-comparison correction; other patterns remain exploratory. This does not establish a shared mechanism or settle any Big Question.
USC plans an 80-person depression study comparing psilocybin therapy with and without mindfulness. A separate, peer-reviewed 10-person optogenetic trial reports limited visual improvements.
Evidence status: The USC programme has no new treatment results. The vision study is small and open-label, with a non-prespecified improvement threshold and reported adverse events.
Evidence status: Small samples and unresolved mechanisms. The full review includes controls, limitations, primary papers, analysis code and questions for BQ011 and TSC2026.
CONSCIOUSNESS & WISDOM WATCH · 8 OCTOBER 2026 · 4 MIN READ
Pain, Psychedelic Research & Public Health
Updated 8 October: human brain imaging, a research consultation, a conceptual analysis and a publisher correction. Each offers a different kind of knowledge. The related psilocybin survey is linked below without counting it again as a new finding.
Chronic-pain flares and the brain’s default-mode network
Empirical research · 5 October 2026. UC San Diego reports publication in the British Journal of Anaesthesia.
What changed: In 114 people with chronic low-back pain, arterial-spin-labeling MRI compared movement-triggered flares with experimentally induced heat pain. Flares increased default-mode-network activity; heat pain decreased it. Greater chronic-pain severity correlated with stronger connectivity between that network and sensory regions.
Why it matters: Laboratory heat pain may represent everyday flares poorly. For AkashicNET, this offers a specific connection between bodily experience and self-related processing.
Evidence and limits: Human neuroimaging with a comparison stimulus. The institutional report was verified; journal full text was inaccessible. Effect sizes, confidence intervals, preregistration and independent replication remain unverified. Network activity alone does not establish that pain becomes part of identity, or demonstrate meditation or psilocybin efficacy.
Research-program update · Announced 5 October; Federal Register notice published 6 October 2026. Official sources checked 8 October.
What changed: The FDA requested input on participant selection, dose escalation, care settings, cardiac and neurological monitoring, stopping rules and independent oversight. Adults with opioid-use disorder and PTSD are initial federal research priorities. Comments close 20 November 2026, under docket FDA-2026-N-10429.
Why it matters: This advances structured investigation and identifies concrete safeguards for proposed trials. AkashicNET can follow subsequent registrations and results.
Evidence and limits: A regulatory consultation supplies no participant outcomes, effect sizes or new efficacy evidence. The proposed early-phase approach prioritises safety, including cardiac monitoring and neurological follow-up. It is preliminary and nonbinding, not a final trial protocol or treatment approval. Safety and benefit remain research questions.
Spiritual and cultural interpretation / policy framework · 7 October 2026. Kenton Bartlett, Lisa L. Gezon, Walter D. Ward and Fanicy Sears, Frontiers in Public Health.
What changed: A conceptual analysis argues that public-health policy should consider spiritual growth, social bonding and ecological connection in non-clinical psychedelic use. It draws on historical and interdisciplinary literature, including colonialism and the origins of prohibition.
Why it matters: It broadens the policy discussion to cultural context, personal choice and collective wellbeing. This is a contemporary argument drawing on older traditions.
Evidence and limits: Peer-reviewed by two anonymous reviewers; accepted 22 September. The retrieved page provides the abstract and says the final formatted article is forthcoming. It reports no new participant dataset, controls or effect estimates. The policy argument does not establish the safety or efficacy of expanded access, nor independently corroborate spiritual or metaphysical claims.
UPDATE · A correction restores a consciousness framework’s terminology
Publisher correction · 6 October 2026.Neuroscience of Consciousness, concerning Valerie van Mulukom’s dual self-states framework.
What changed: The publisher says production edits made after author proof review mistakenly replaced multiple instances of “reflective” with “reflective/experiential”. The notice reports that these substitutions have been reversed.
Why it matters: The distinction between reflective and experiential self-states is part of the framework’s argument. Read the correction alongside the original when quoting or interpreting it.
Evidence and limits: This is a textual correction to a theoretical framework, with no new sample, measurements or replication. It does not validate the framework or resolve consciousness-continuity claims.
Related coverage:Psilocybin use and unmet care needs — a 6,793-person survey analysis found higher reported unmet need among users, alongside nonsignificant treatment-use associations. This previously covered study is not an independent replication or a new trial.
AKN24 · 7 OCTOBER 2026 · 3 MIN READ
Care Needs, Cosmic Neutrinos & the Solar Outlook
A psilocybin survey examines unmet care needs, NOAA forecasts possible storming on 9 October, NASA updates SunRISE’s timetable, and a Physics Nobel recognises neutrino astronomy. Findings, forecasts and future goals remain distinct.
Psilocybin use and unmet mental-health needs
Published: 6 October 2026 · Psychological Medicine · Cross-sectional survey analysis.
Observation: Researchers analysed 6,793 US respondents aged 12 or older with a past-year major depressive episode. Adjusted analyses found no significant association between psilocybin use and conventional treatment utilisation. Perceived unmet need was higher among users: 52.0% versus 33.9%; adjusted prevalence ratio 1.44 (95% confidence interval 1.04–2.01).
Interpretation: These associations concern care patterns, not treatment effectiveness. Nonsignificant treatment-use comparisons do not establish equivalence or show whether individual users continued or abandoned care.
Hypothesis: Unmet needs might motivate use; the direction cannot be established here.
Testimony: Drug use, treatment and unmet need were self-reported.
Speculation: This study does not test benefits from microdosing or personalised dose titration.
Unresolved: Temporal direction, residual confounding and exploratory comparisons without multiplicity correction. Dose, frequency and setting were not captured.
Issued: 7 October 2026 at 00:30 UTC / 02:30 Berlin. Dated forecast snapshot.
Observation: The highest measured three-hour Kp in the preceding day was 3, below storm level.
Forecast: NOAA forecasts possible minor-to-moderate storming on 9 October. The highest predicted interval is Kp 5.67 (G2), 09:00–12:00 UTC / 11:00–14:00 Berlin.
Interpretation: NOAA attributes the outlook to the anticipated arrival of a coronal mass ejection. This is not a storm already observed.
Hypothesis: No additional newsroom hypothesis.
Testimony: Not applicable.
Speculation: No effect on mood, consciousness, health or spiritual experience is inferred.
Published: 6 October 2026 · NASA mission announcement.
Observation: NASA reports completed assembly and testing for SunRISE, a six-spacecraft radio observatory designed to investigate solar energetic particles. Launch is targeted no earlier than mid-2027.
Interpretation: This updates the timetable for future solar research; it is not a new measurement of solar activity.
Hypothesis: Future observations could improve understanding of particle acceleration and support better forecasting.
Testimony: NASA’s institutional account of mission readiness.
Speculation: Improved forecasting remains a goal; links to human experience are unsupported here.
Unresolved: Exact launch date, commissioning and scientific performance.
Physics Nobel recognises cosmic-neutrino discoveries
Announced: 6 October 2026 · Institutional announcement.
Observation: Francis Halzen received the 2026 Physics Nobel for contributions to IceCube and the discovery of high-energy astrophysical neutrinos. The award recognises established detector work and discoveries, rather than announcing a new dataset.
Interpretation: Neutrino astronomy offers another way to investigate distant energetic sources and illustrates how elusive phenomena can be measured.
Hypothesis: Improved instruments may identify more sources.
Testimony: Researchers’ reflections provide context, separate from measurements.
Speculation: These findings provide no evidence for psi or non-local consciousness.
Unresolved: Many neutrino origins remain under investigation. IceCube expects its upgrade’s first science data later this year.
No Big Question evidence scores have been changed by this briefing.
AKN24 · 6 OCTOBER 2026 · 3 MIN READ
Archive: This edition retains its original dates. See the 7 October bulletin for the newer space-weather outlook.
Light, Brain Circuits & a Quieter Space-Weather Outlook
A Nobel milestone for neuroscience, an early-stage psychedelic research initiative and a fresh NOAA bulletin. Each story keeps the announcement, evidence and unanswered questions distinct.
Optogenetics recognised by the 2026 medicine Nobel
Published: 5 October 2026 · Institutional announcement.
Observation: Karl Deisseroth, Peter Hegemann and Georg Nagel share the prize for work leading to optogenetics: using light-sensitive proteins to control selected cells. The method lets researchers experimentally test the contribution of particular neural circuits.
Interpretation: This is a milestone for investigating brain function through targeted interventions.
Hypothesis: Better circuit understanding may inform future treatments; that prospect needs separate clinical evidence.
Testimony: The announcement includes researchers’ personal reflections; these are distinct from experimental results.
Speculation: The award does not establish a complete explanation of subjective experience.
Unresolved: Which experimental findings translate safely into clinical benefit, and how circuit mechanisms relate to lived experience.
Ibogaine: research planning, not a treatment result
Source update · 8 October: The FDA announcement has now been checked, including the consultation scope and deadline. The original coverage below is retained as a dated record.
Published: 5 October 2026 · Reuters reporting.
Observation: Reuters reports that US officials are advancing government-funded early-stage ibogaine trials and seeking input on study safeguards.
Interpretation: This is a research-policy development.
Issued: 6 October 2026 at 00:30 UTC / 02:30 Berlin. Dated snapshot, not a live measurement.
Observation: The highest three-hour Kp in the preceding 24 hours was 5 (G1, Minor). NOAA also recorded an R1 radio blackout, with the largest at 18:48 UTC on 5 October.
Forecast: Maximum predicted Kp is 4 for 6–8 October, below storm scale. NOAA expects no G1-or-greater geomagnetic storms in that period.
Interpretation: The forecast indicates easing geomagnetic activity.
Hypothesis / testimony: Not applicable to this operational bulletin.
Speculation: No effect on mood, consciousness, health or spiritual experience is inferred.
Unresolved: Actual conditions may differ from the forecast.
Conference watch: TSC2026 remains 11–16 October in San Diego. Our 6 October programme check covers workshop rooms, arrival and dinner availability.
No evidence scores have been changed by this briefing.
AKN24 · 5 OCTOBER 2026 · 4 MIN READ
Archive: This edition retains its original dates. For the updated space-weather outlook, see the 11 October bulletin.
Space Weather, Consciousness Questions & Voices From the Moon
Observed geomagnetic storming leads this edition, alongside a clinical research perspective, an AI-consciousness preprint and NASA mission audio. Observation, interpretation and open questions remain distinct.
G2 observed; early G1 forecast, then easing
NOAA bulletin issued 5 October 2026 at 00:30 UTC / 02:30 Berlin.
Observation: Maximum observed three-hour Kp in the preceding 24 hours was 6, NOAA G2 Moderate storm level.
Forecast: The highest predicted interval on 5 October is Kp 4.67 (G1), 00:00–03:00 UTC / 02:00–05:00 Berlin, followed by easing conditions.
Interpretation: NOAA attributes the outlook to a positive-polarity coronal-hole high-speed stream.
Hypothesis: No additional hypothesis proposed.
Testimony: Not applicable.
Speculation: No effect on mood, health, consciousness or spiritual experience is inferred.
Unresolved: Subsequent storm intensity and duration require fresh observations.
Published 3 October 2026 · Molecular Psychiatry · Perspective; no new patient dataset.
Observation: The perspective reviews preliminary work. A cited 2025 single-patient psilocybin report found greater EEG complexity and new spontaneous behaviours, but no improvement on validated behavioural scales or in diagnosis.
Interpretation: Physiological changes alone cannot establish recovery of awareness.
Hypothesis: Changes in network dynamics and plasticity might support recovery in some patients.
Testimony: Observed behaviours are distinct from verified accounts of subjective experience.
Speculation: The evidence does not establish that psychedelics awaken coma patients.
Unresolved: Controlled evidence of sustained recovery, safety, consent, patient selection and reliable outcomes. Full perspective text was subscription-restricted; this summary uses its abstract and the cited case report.
Editorial note: No Big Question scores or evidence statuses have been promoted. Lunar coverage concerns the Solar System, not a new interstellar-object discovery. The 1 October psilocybin-context highlight repeats previously covered research; the October-issue blinding paper first appeared online on 28 May and is not new October research.